REPLIMUNE GROUP, INC. OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax
REPLIMUNE GROUP, INC. (REPL) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax of $0 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax · last filed 2025-08-07
- REPLIMUNE GROUP, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2025-06-30 was $0.00.
- REPLIMUNE GROUP, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2025-03-31 was $0.00.
- REPLIMUNE GROUP, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2024-12-31 was $0.00.
- REPLIMUNE GROUP, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2024-09-30 was $0.00.
- REPLIMUNE GROUP, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2025 was $0.00.
- REPLIMUNE GROUP, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2024 was $0.00.
- REPLIMUNE GROUP, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2023 was $0.00.
- REPLIMUNE GROUP, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2022 was $0.00.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 2 quarters · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | $0.00 derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | $0.00 derived: sum of 2 quarters · filed 2025-05-22 | $0.00 derived: sum of 3 quarters · filed 2025-05-22 | $0.00 10-K · filed 2025-05-22 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-12 | $0.00 derived: sum of 2 quarters · filed 2025-02-12 | $0.00 10-Q · filed 2025-02-12 | $0.00 derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | $0.00 derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 2 quarters · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | $0.00 derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | $0.00 derived: sum of 2 quarters · filed 2025-05-22 | $0.00 derived: sum of 3 quarters · filed 2025-05-22 | $0.00 10-K · filed 2025-05-22 |
| 2023-12-31 | $0.00 10-Q · filed 2025-02-12 | $0.00 derived: sum of 2 quarters · filed 2025-02-12 | $0.00 10-Q · filed 2025-02-12 | $0.00 derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 3 quarters · filed 2024-11-12 | $0.00 derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 2 quarters · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-08-08 | $0.00 derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $0.00 derived: sum of 2 quarters · filed 2024-05-16 | $0.00 derived: sum of 3 quarters · filed 2024-05-16 | $0.00 10-K · filed 2024-05-16 |
| 2022-12-31 | $0.00 10-Q · filed 2024-02-08 | $0.00 derived: sum of 2 quarters · filed 2024-02-08 | $0.00 10-Q · filed 2024-02-08 | $0.00 derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 3 quarters · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 derived: sum of 2 quarters · filed 2023-08-03 | $0.00 derived: sum of 3 quarters · filed 2023-08-03 | $0.00 derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | $0.00 derived: sum of 2 quarters · filed 2023-05-18 | $0.00 derived: sum of 3 quarters · filed 2023-05-18 | $0.00 10-K · filed 2023-05-18 |
| 2021-12-31 | $0.00 10-Q · filed 2023-02-09 | $0.00 derived: sum of 2 quarters · filed 2023-02-09 | $0.00 10-Q · filed 2023-02-09 | |
| 2021-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $0.00 10-K · filed 2021-05-20 | |||
| 2020-03-31 | $0.00 10-K · filed 2021-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |